Compounding with Controlled Substances

Author(s):  Whalen Mary Kate

Issue:  Jan/Feb 2002 - Compounding for Pain Management and Dental Medicine
View All Articles in Issue

Abstract:  The author, an attorney, provides an overview of the Controlled Substances Act and US Drug Enforcement Administration regulations regarding compounding and highlights recent issues regarding the use of controlled substances in formulations. She concludes that compounding pharmacists who compound controlled substances within the parameters for authorized compounding established by their state boards of pharmacy and US Food and Drug Administration guidelines should not have problems with their local Drug Enforcement Administration field office. However, if problems do arise, enforcement actions vary with each field office.

Related Keywords: Controlled substances DEA narcotic CSA FDA "Negative List"

Related Categories: BUSINESS, LEGAL

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=321

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products